These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15136792)

  • 61. The biotech drug market.
    Lawrence S
    Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645
    [No Abstract]   [Full Text] [Related]  

  • 62. Market watch: Upcoming catalysts in Q3 2014.
    Haggerty R
    Nat Rev Drug Discov; 2014 Jul; 13(7):486. PubMed ID: 24981351
    [No Abstract]   [Full Text] [Related]  

  • 63. The antibiotic paradox: why companies can't afford to create life-saving drugs.
    McKenna M
    Nature; 2020 Aug; 584(7821):338-341. PubMed ID: 32814891
    [No Abstract]   [Full Text] [Related]  

  • 64. Tempered enthusiasm. Drug-safety law needs more teeth, patient-safety advocates say.
    DerGurahian J
    Mod Healthc; 2007 Oct; 37(40):16. PubMed ID: 18018373
    [No Abstract]   [Full Text] [Related]  

  • 65. "Creating hope" and other incentives for drug development for children.
    Connor E; Cure P
    Sci Transl Med; 2011 Jan; 3(66):66cm1. PubMed ID: 21248312
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Market watch: Upcoming market catalysts in Q2 2013.
    Nguyen K
    Nat Rev Drug Discov; 2013 Apr; 12(4):254. PubMed ID: 23535926
    [No Abstract]   [Full Text] [Related]  

  • 67. Regulators adopt more orphan drugs.
    Reardon S
    Nature; 2014 Apr; 508(7494):16-7. PubMed ID: 24695293
    [No Abstract]   [Full Text] [Related]  

  • 68. Are drugmakers fishing for a market with prescription omega-3s?
    Hersher R
    Nat Med; 2012 Jan; 18(1):6. PubMed ID: 22227649
    [No Abstract]   [Full Text] [Related]  

  • 69. Drug safety special: the safety catch.
    Wadman M
    Nature; 2005 Mar; 434(7033):554-6. PubMed ID: 15800591
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical research: outlook from industry.
    Echols R
    Clin Perform Qual Health Care; 1996; 4(2):113-4. PubMed ID: 10156942
    [No Abstract]   [Full Text] [Related]  

  • 71. The decreased number of new drug approvals (NDAs) has been a topic of considerable debate over the past decade. Preface.
    Enna SJ; Williams M
    Adv Pharmacol; 2009; 57():xi-ii. PubMed ID: 19945649
    [No Abstract]   [Full Text] [Related]  

  • 72. Market watch: Upcoming market catalysts in Q3 2017.
    Nghiem S
    Nat Rev Drug Discov; 2017 Jul; 16(7):449. PubMed ID: 28620177
    [No Abstract]   [Full Text] [Related]  

  • 73. The art of the alliance.
    Menzel GE; Xanthopoulos KG
    Nat Biotechnol; 2012 Apr; 30(4):313-5. PubMed ID: 22491275
    [No Abstract]   [Full Text] [Related]  

  • 74. Vouchers for FDA priority reviews.
    Spatz ID
    Health Aff (Millwood); 2006; 25(4):1184; author reply 1184-5. PubMed ID: 16835203
    [No Abstract]   [Full Text] [Related]  

  • 75. New IGF drug stirs competition in growth factor segment.
    Ratner M
    Nat Biotechnol; 2005 Oct; 23(10):1192. PubMed ID: 16211044
    [No Abstract]   [Full Text] [Related]  

  • 76. Top 100 bestselling drugs represent an arena struggling for new FDA approvals: drug age as an efficiency indicator.
    Polanski J; Bogocz J; Tkocz A
    Drug Discov Today; 2015 Nov; 20(11):1300-4. PubMed ID: 26160060
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drugmaker reaps what it sows with first plant-made biologic.
    Williams SC
    Nat Med; 2012 Jan; 18(1):5. PubMed ID: 22227648
    [No Abstract]   [Full Text] [Related]  

  • 78. Biosimilars battle rages on, Amgen fights both sides.
    Senior M
    Nat Biotechnol; 2013 Apr; 31(4):269-70. PubMed ID: 23563402
    [No Abstract]   [Full Text] [Related]  

  • 79. Market watch: Upcoming market catalysts in Q1 2018.
    Collins T
    Nat Rev Drug Discov; 2018 Dec; 17(1):8-9. PubMed ID: 29282372
    [No Abstract]   [Full Text] [Related]  

  • 80. America's other drug problem: how the drug industry distorts medicine and politics.
    Relman AS; Angell M
    New Repub; 2002 Dec; 227(25):27-41. PubMed ID: 12561803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.